• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Pediatrics

Children with intellectual and developmental disabilities have increased risks of depression and anxiety

byDeepti Shroff
October 14, 2026
in Pediatrics, Psychiatry
Reading Time: 3 mins read
Children with intellectual and developmental disabilities have increased risks of depression and anxiety
Share on FacebookShare on TwitterShare on LinkedIn

1. Children who had an intellectual and developmental disabilities (IDD) had significantly higher risks of depression and anxiety compared with those without IDD

2. The association between IDD and having depression and anxiety was strongest among males, those with mild comorbidity burdens, and younger children and urban residents compared to their counterparts who did not have IDD.

Evidence Rating Level: 2 (Good)

Study Rundown: The global prevalence of IDD among children and adolescents in 2019 was 2%. Especially among children and adolescents, neurodevelopmental conditions have significant impacts and implications on their health and wellbeing. In this population based retrospective cohort study, researchers investigated the risks of developing depression and anxiety among children with IDD. The data for the study came from South Korea’s National Health Insurance Service database (NHIS) and National Disability Registration System (NDRS). In total, 236132 children were included as part of the study. The ages ranged from 2-17 years and those diagnosed with IDD were matched in a 1:3 ratio with children without developmental disorders, by sex and birth year. The results of this study demonstrated that children with IDD head significantly higher risk of having depression and anxiety and compared to children without IDD. The study was limited by its reliance on administrative health records, which may have resulted in misclassification of IDD, depression, and anxiety diagnoses, as well as an inability to account for potentially important confounding factors. Additionally, the observational study design limits causal interpretation, and the findings may not be generalizable to populations outside South Korea.

Click to read this study in JAMA

Relevant Reading: Co-Occurring Conditions in Autism: Understanding the Overlap with Anxiety, Depression, and More

RELATED REPORTS

Post-traumatic stress disorder is associated with increased risk of mild cognitive impairment and dementia among United States Veterans

Frailty in older adults with atrial fibrillation is multifactorial and associated with metabolic and cognitive factors

Alcohol use declines but remains above pre-pandemic levels

In-Depth [retrospective cohort]: In this retrospective cohort, the date of IDD diagnosis was defined as the date of first registration in the National Disability Registration System (NDRS). As such, it is important to note that this may not reflect the exact age at which symptoms first appeared. Children registered with IDD before the age of two were excluded, as were those with a previous diagnosis of depression or anxiety or those who developed either condition within the first year after baseline. These exclusion criteria were applied uniformly to participants with and without IDD, who were matched at a 1:3 ratio. Overall, 25% of the 236,132 children had IDD. Among these children, 20.1% were diagnosed with depression and 21.9% with anxiety during follow-up. Compared with children without developmental disorders, children with IDD had higher relative risks of depression and anxiety, particularly among males (adjusted HR [AHR], 2.46 [95% CI, 2.39–2.54] and 2.06 [95% CI, 2.00–2.12], respectively) and urban residents (AHR, 2.36 [95% CI, 2.25–2.48] and 1.97 [95% CI, 1.88–2.06], respectively). Younger age was also associated with higher relative risks of depression and anxiety among children with IDD compared with children without developmental disorders, particularly among those aged 2–5 years (AHR, 2.83 [95% CI, 2.66–3.01] and 2.41 [95% CI, 2.27–2.55], respectively) and those aged 6–8 years (AHR, 2.51 [95% CI, 2.40–2.64] and 2.12 [95% CI, 2.02–2.22], respectively). The findings of the study highlight the importance of increased mental health screening and targeted interventions based on patients’ sociodemographic backgrounds and existing comorbidities. Improved access to mental health resources may help address the increased risks of depression and anxiety in this population.

© 2026 2 Minute Medicine, Inc. All rights reserved. No part of this article may be reproduced, distributed or transmitted in any form or by any means without the prior written permission of 2 Minute Medicine, Inc. To license this content, contact 2 Minute Medicine, Inc. This article is for informational and educational purposes only; it is not medical advice and does not replace the judgment of a qualified healthcare professional.
Image: © 2 Minute Medicine

Tags: anxietychildrendepressionhealthstudy
Previous Post

Gabapentin (Neurontin) prescription for chronic low back pain in adults is associated with a higher risk of dementia

RelatedReports

Chronic Disease

Post-traumatic stress disorder is associated with increased risk of mild cognitive impairment and dementia among United States Veterans

October 2, 2026
Cardiology

Frailty in older adults with atrial fibrillation is multifactorial and associated with metabolic and cognitive factors

September 30, 2026
Psychiatry

Alcohol use declines but remains above pre-pandemic levels

September 22, 2026
Emergency

The rotavirus vaccine (ROTASIIL) may reduce the incidence of hospitalization for rotavirus gastroenteritis in children

September 21, 2026
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Children with intellectual and developmental disabilities have increased risks of depression and anxiety
  • Gabapentin (Neurontin) prescription for chronic low back pain in adults is associated with a higher risk of dementia
  • The rate of urethrocutaneous fistula formation may be similar between caudal and penile blocks
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.